COLL vs DDOG · P/E 17, rev $181.9M vs P/E 292, rev $3.43B
Collegium Pharmaceutical Inc (COLL) versus Datadog Inc (DDOG) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Datadog Inc (DDOG) is a software - application company listed on US. It is led by Olivier Pomel.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported DDOG revenue for 2025-12-31 was $3.43B. Net income was $107.7M. Revenue was up 27.7% from 2024-12-31 to 2025-12-31. DDOG currently screens at market cap $47.44B and trailing P/E 292.3.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. DDOG currently screens at market cap $47.44B and trailing P/E 292.3.
Not investment advice. Open the COLL and DDOG stock pages for the full models.
Not investment advice.